Short communication · 30 Apr 2026
Conference abstractPublished 29 Aug 2017
Influence of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) on morbidity and start of adjuvant chemotherapy in patients with ovarian cancer
HELIOS Hospital, Germany
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Epithelial ovarian cancer, tubal cancer and primary peritoneal cancer may lead to early peritoneal metastases and are frequently only diagnosed, when extensive peritoneal carcinomatosis exists. A treatment option of advanced ovarian cancer is the combination of maximal surgical cytoreduction followed by chemotherapy. Studies could demonstrate that the extent of cytoreduction is directly correlated to survival. In cases where complete cytoreduction could be achieved, intraperitoneal chemotherapy with cisplatin results in a better prognosis. The application of HIPEC induces an increased cytotoxicity of cisplatin and may therefore improve the efficacy of the therapy. As yet it remains unclear, whether the additional use of HIPEC increases the morbidity or induces a delay of adjuvant chemotherapy. Data of 98 patients treated with HIPEC (50 mg/m2 cisplatin) in the years 2012 to 2015 for advanced ovarian, tubal or peritoneal cancer were retrospectively analyzed with regard to morbidity and consecutive begin of chemotherapy. HIPEC was not associated with increased morbidity such as insufficencies of anastomoses, infections or other major complications. In all patients use of HIPEC did not delay timing of the consecutive chemotherapy. In ovarian cancer management of patients with cytoreductive surgery and HIPEC with cisplatin 50mg/mÃ?² is a feasible treatment option that is not combined with an increased rate of complications or prolongation of adjuvant chemotherapy.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Gynecology & Obstetrics.
Conference abstract · 19 Nov 2025
Loss of lncRNAs 1700101O22Rik and 1700027A15Rik causes sperm malformation and subfertility
Conference abstract · 19 Nov 2025
Linking Mitochondrial Fatty Acid Metabolism to Follicular Health: A Novel Perspective on Premature Ovarian Insufficiency
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalGynecology & Obstetrics
- SubjectReproductive Medicine & Gynaecology
- BylineArticles whose byline prints “Michael Friedrich”
